Skip to content

Researchers

Our research is structured into research themes, programs of work and teams. We are committed to collaboration and to work together.

Research theme leaders

Associate Professor Glenn Pearson

BA (Education) PhD Candidate

Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research

Head, Chronic Diseases Research

Professor Hannah Moore

OAM BSc (Hons) GradDipClinEpi PhD

Head, Infectious Diseases Research

Theme Head, Wellbeing and Mental Health

Timo Lassmann

BSc (Hons) MSc PhD

Feilman Fellow; Head, Precision Health Research and Head, Translational Intelligence

Head, Strong Beginnings Research, Co-head Foundations of Lung Disease

Opportunities

Shaping excellence

Rewarding excellence

Learn more about how The Kids rewards research excellence

Learn more about how The Kids rewards research excellence

Research governance

We pride ourselves on conducting research to the highest standards possible

Find out more about research governance

Current career opportunities

Want to join our team and help make a difference to child health?

Learn more about Current career opportunities

Help shape our research

Find out how you can involve consumers and the community in your research

Help shape our research
Latest

Reports & findings

Chlorinated drinking water exposure enriches antimicrobial resistance pathways in the infant gut microbiome: a randomized trial

Water chlorination is essential for controlling harmful microbes in drinking water; however, the antimicrobial effects of chlorine-based disinfectants present in tap water may influence early-life gut microbial ecology.

Acceptability and Utility of a Virtual Reality Diabetes-Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi-Experimental Case Series Study

To test the utility and acceptability of a novel VR training tool for community health practitioners in assessing diabetes-related foot disease in Aboriginal and Torres Strait Islander people.

Platform trial in COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters

PICOBOO is a randomised, adaptive trial evaluating the immunogenicity and reactogenicity of licensed COVID-19 booster vaccines in immunocompetent individuals >12 years old. Here, we present data for seven different vaccines among three pre-specified participant strata defined by age and primary vaccine schedule.

FEF25–75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study

Existing trajectory studies have emphasised large-airway indices, but chronic obstructive pulmonary disease (COPD) might originate in smaller airways. This study aimed to investigate mid-to-small-airway function trajectories, their associated factors, and COPD risk.